The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Background To evaluate usability of slice-reduced sequential computed tomography (CT) compared to standard high-resolution CT (HRCT) in patients with systemic sclerosis (SSc) for qualitative and quantitative assessment of interstitial lung disease (ILD) with respect to (I) detection of lung parenchymal abnormalities, (II) qualitative and semiquantitative visual assessment, (III) quantification of ILD by histograms and (IV) accuracy for the 20%-cut off discrimination. Methods From standard chest HRCT of 60 SSc patients sequential 9-slice-computed tomography (reduced HRCT) was retrospectively reconstructed. ILD was assessed by visual scoring and quantitative histogram parameters. Results from standard and reduced HRCT were compared using non-parametric tests and analysed by univariate linear regression analyses. Results With respect to the detection of parenchymal abnormalities, only the detection of intrapulmonary bronchiectasis was significantly lower in reduced HRCT compared to standard HRCT (P=0.039). No differences were found comparing visual scores for fibrosis severity and extension from standard and reduced HRCT (P=0.051-0.073). All scores correlated significantly (P<0.001) to histogram parameters derived from both, standard and reduced HRCT. Significant higher values of kurtosis and skewness for reduced HRCT were found (both P<0.001). In contrast to standard HRCT histogram parameters from reduced HRCT showed significant discrimination at cut-off 20% fibrosis (sensitivity 88% kurtosis and skewness; specificity 81% kurtosis and 86% skewness; cut-off kurtosis ≤26, cut-off skewness ≤4; both P<0.001). Conclusions Reduced HRCT is a robust method to assess lung fibrosis in SSc with minimal radiation dose with no difference in scoring assessment of lung fibrosis severity and extension in comparison to standard HRCT. In contrast to standard HRCT histogram parameters derived from the approach of reduced HRCT could discriminate at a threshold of 20% lung fibrosis with high sensitivity and specificity. Hence it might be used to detect early disease progression of lung fibrosis in context of monitoring and treatment of SSc patients.

[1]  T. Frauenfelder,et al.  Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study , 2014, Annals of the rheumatic diseases.

[2]  David A Lynch,et al.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.

[3]  Klaus Krippendorff,et al.  Answering the Call for a Standard Reliability Measure for Coding Data , 2007 .

[4]  U. Müller-Ladner,et al.  Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database , 2012, Annals of the rheumatic diseases.

[5]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[6]  William H. Judy,et al.  The Measurement, Reporting, and Management of Radiation Dose in CT , 2008 .

[7]  D. Hansell,et al.  Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.

[8]  U. Müller-Ladner,et al.  Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis , 2013, Annals of the rheumatic diseases.

[9]  H. Alkadhi,et al.  Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices , 2011, Annals of the rheumatic diseases.

[10]  Barbara L. Welther,et al.  The impact , 1995 .

[11]  D. Hansell,et al.  High resolution computed tomography as a predictor of lung histology in systemic sclerosis. , 1992, Thorax.

[12]  F. Mendoza,et al.  Treatment of rapidly progressive systemic sclerosis: current and futures perspectives , 2016, Expert opinion on orphan drugs.

[13]  Sana Boudabbous,et al.  Computed tomography of the chest with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination: preliminary observations , 2013, European Radiology.

[14]  Radiological protection and safety in medicine. A report of the International Commission on Radiological Protection. , 1996, Annals of the ICRP.

[15]  Jonathan H. Chung,et al.  Radiological approach to interstitial lung disease: a guide for the nonradiologist. , 2012, Clinics in chest medicine.

[16]  J. Anaya,et al.  Pulmonary involvement in systemic sclerosis. , 2016, Autoimmunity reviews.

[17]  P. Emery,et al.  A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. , 2006, Arthritis and rheumatism.

[18]  Eric Hachulla,et al.  Effect of Iterative Reconstruction on the Detection of Systemic Sclerosis-related Interstitial Lung Disease: Clinical Experience in 55 Patients. , 2016, Radiology.

[19]  J. Fries,et al.  Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. , 1969, The American journal of medicine.

[20]  U. Müller-Ladner,et al.  Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database , 2007, Annals of the rheumatic diseases.

[21]  G. van Kaick,et al.  Usual interstitial pneumonia. Quantitative assessment of high-resolution computed tomography findings by computer-assisted texture-based image analysis. , 1997, Investigative radiology.

[22]  R. Elashoff,et al.  Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. , 2009, Chest.

[23]  J. Gran,et al.  Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic Sclerosis , 2015, Arthritis & rheumatology.

[24]  H. Kauczor,et al.  Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT) , 2015, PloS one.

[25]  Sumit K. Shah,et al.  Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide , 2011, European Radiology.

[26]  Gary K Grunwald,et al.  Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment. , 2003, Radiology.

[27]  N. Sverzellati,et al.  Evaluation of quantitative CT indexes in idiopathic interstitial pneumonitis using a low-dose technique. , 2005, European journal of radiology.

[28]  David J Brenner,et al.  Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. , 2004, Radiology.

[29]  A. Devaraj.  Imaging: how to recognise idiopathic pulmonary fibrosis , 2014, European Respiratory Review.

[30]  H. Tiddens,et al.  Dose reduction for CT in children with cystic fibrosis: is it feasible to reduce the number of images per scan? , 2005, Pediatric Radiology.

[31]  Charlie Strange,et al.  Cyclophosphamide versus placebo in scleroderma lung disease. , 2006, The New England journal of medicine.

[32]  Ø. Molberg,et al.  Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis , 2016, Current opinion in rheumatology.

[33]  H. Itoh,et al.  Usual interstitial pneumonia: histologic correlation with high-resolution CT. , 1992, Radiology.

[34]  N. Goh,et al.  Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. , 2013, Rheumatology.

[35]  K. Krippendorff.  Reliability in Content Analysis: Some Common Misconceptions and Recommendations , 2004 .

[36]  Stefano Diciotti,et al.  Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. , 2007, Chest.

[37]  M. Boubaya,et al.  Mapping and predicting mortality from systemic sclerosis , 2017, Annals of the rheumatic diseases.

[38]  J. Remy,et al.  Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. , 1993, Radiology.

[39]  N. Lee,et al.  Diagnosis and assessment of pulmonary arterial hypertension , 2010 .

[40]  A Kahn,et al.  Interstitial lung disease. , 1982, The Journal of the Arkansas Medical Society.

[41]  Takeshi Johkoh,et al.  Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. , 2002, Radiology.

[42]  Gary K Grunwald,et al.  Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. , 2008, Radiology.

[43]  S. Mehrain,et al.  Regional heterogeneity of air trapping at expiratory thin-section CT of patients with bronchiolitis: potential implications for dose reduction and CT protocol planning. , 2008, Radiology.

[44]  Klaus Krippendorff,et al.  Content Analysis: An Introduction to Its Methodology , 1980 .

[45]  Jonathan G Goldin,et al.  High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. , 2008, Chest.

[46]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[47]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[48]  R. Speich,et al.  Pulmonary Function Tests: High Rate of False Negatives in the Early Detection and Screening of Scleroderma Interstitial Lung Disease , 2015 .

[49]  R. Takei,et al.  Radiographic fibrosis score predicts survival in systemic sclerosis‐associated interstitial lung disease , 2018, Respirology.

[50]  A. Nicholson,et al.  Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. , 2000, Radiology.